Clinical Trial Update: A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating long-acting injectable risperidone for methamphetamine dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Dependence

Drugs mentioned

• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Seattle Institute for Biomedical and Clinical Research | Conditions: Methamphetamine Dependence | Phase 2 | Status: COMPLETED